GoodRx Holdings, Inc. Deferred Federal, State and Local, Tax Expense (Benefit)
GoodRx Holdings, Inc. (GDRX) reported Deferred Federal, State and Local, Tax Expense (Benefit) of $20.07 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit · last filed 2026-02-26
- GoodRx Holdings, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2025 was $20.07M.
- GoodRx Holdings, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2024 was -$11.91M.
- GoodRx Holdings, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2023 was -$65.56M.
- GoodRx Holdings, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2022 was -$497.00K, a 103.85% decline from fiscal 2021.
| Period end | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $20.07M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$11.91M 10-K · filed 2026-02-26 |
| 2023-12-31 | -$65.56M 10-K · filed 2026-02-26 |
| 2022-12-31 | -$497.00K 10-K · filed 2025-02-27 |
| 2021-12-31 | $12.91M 10-K · filed 2024-02-29 |
| 2020-12-31 | -$10.91M 10-K · filed 2023-03-01 |
| 2019-12-31 | -$5.67M 10-K · filed 2022-03-01 |
| 2018-12-31 | -$2.43M 10-K · filed 2021-03-12 |